Table 2 Distribution of HPV type infection by age group (N = 571)
Age group | Overall (N=571) | 16–19 (n’=8) | 20–24 (n’=77) | 25–34 (n’=246) | 35–44 (n’=106) | 45–54 (n’=88) | ≥55 (n’=46) | |||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
n | 95% CI (LL–UL) | n | 95% CI (LL–UL) | n | 95% CI (LL–UL) | n | 95% CI (LL–UL) | n | 95% CI (LL–UL) | n | 95% CI (LL–UL) | n | 95% CI (LL–UL) | |
HPV - | 515 | 90.2 (87.5–92.5) | 6 | 75 (34.9–96.8) | 72 | 93.5 (85.5–97.9) | 217 | 88.2 (83.5–92.0) | 97 | 91.5 (84.5–96.0) | 82 | 93.2 (85.7–97.5) | 41 | 89.1 (76.4–96.4) |
HPV + | 56 | 9.8 (7.5–12.5) | 2 | 25 (3.2–65.1) | 5 | 6.5 (2.1–14.5) | 29 | 11.8 (8.0–16.5) | 9 | 8.5 (4.0–15.5) | 6 | 6.8 (2.5–14.3) | 5 | 10.9 (3.6–23.6) |
Single infection | 28 | 4.9 (3.3–7.0) | 1 | 12.5 (0.3–52.7) | 2 | 2.6 (0.3–9.1) | 14 | 5.7 (3.1–9.4) | 4 | 3.8 (1.0–9.4) | 5 | 5.7 (1.9–12.8) | 2 | 4.3 (0.5–14.8) |
Multiple infection | 15 | 2.6 (1.5–4.3) | 1 | 12.5 (0.3–52.7) | 1 | 1.3 (0–7.0) | 7 | 2.8 (1.2–5.8) | 3 | 2.8 (0.6–8.0) | 1 | 1.1 (0–6.2) | 2 | 4.3 (0.5–14.8) |
Infection with unidentifiable HPV type* | 13 | 2.3 (1.2–3.9) | 0 | 0 (0–36.9) | 2 | 2.6 (0.3–9.1) | 8 | 3.3 (1.4–6.3) | 2 | 1.9 (0.2–6.6) | 0 | 0 (0–4.1) | 1 | 2.2 (0.1–11.5) |